AXGT - Axovant Gene Therapies Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5200.46M
Enterprise Value 3125.65M
Trailing P/E N/A
Forward P/E 1-1.28
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.53
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.93

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-58.85%
Return on Equity (ttm)-224.62%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -134.66M
Net Income Avi to Common (ttm)-145.34M
Diluted EPS (ttm)-1.2490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)84.94M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)48.83M
Total Debt/Equity (mrq)214.56
Current Ratio (mrq)2.02
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)-155.73M
Levered Free Cash Flow (ttm)-96.88M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.08
52-Week Change 3∞%
S&P500 52-Week Change 38.63%
52 Week High 32.4500
52 Week Low 30.9300
50-Day Moving Average 31.3222
200-Day Moving Average 31.2266

Share Statistics

Avg Vol (3 month) 32.5M
Avg Vol (10 day) 31.03M
Shares Outstanding 5182.24M
Float 55.61M
% Held by Insiders 158.22%
% Held by Institutions 117.40%
Shares Short (Mar 29, 2019) 47.11M
Short Ratio (Mar 29, 2019) 41.64
Short % of Float (Mar 29, 2019) 412.89%
Short % of Shares Outstanding (Mar 29, 2019) 44.57%
Shares Short (prior month Feb 28, 2019) 44.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A